title: [Outcome of non-operated adrenal masses in 126 patients observed from 1986 to 1999].
abstract: OBJECTIVE
  CT scan performed for non-adrenal related symptoms detects an adrenal mass or 'incidentaloma' in 0.4 to 4.3% of cases, and most authors advocate a non-operative policy, after minimal but careful work-up aimed at excluding pheochromocytoma and aldosteronoma. The breakthrough of laparoscopic adrenalectomy has led some to challenge this attitude. This retrospective study focused on the outcome of non-operated adrenal masses.
  
  
  METHODS
  From 1986 through 1999, 126 patients (64 men and 62 women) presented with an incidental mass of the adrenal fossa, and a non-surgical attitude was elicited. Mean size was 36.5 mm in diameter. All patients underwent an in-depth clinical, biochemical and imaging work-up. They have been stratified into two groups: group I: no contraindication to surgery (n = 95); and group II: contraindication to surgery (frail patients, invasive adrenal or metastatic extra-adrenal cancer) (n = 31).
  
  
  RESULTS
  With a mean follow-up of 4.3 years, 17 patients were lost to follow-up (13.5%), including 11/95 in group I; 36 were dead (28.5%), including 12/95 in group I (no adrenal-related death) and 24/31 in group II; 72 were alive and well without operation, including only one in group II; one patient was operated for a benign adrenal adenoma removed at the time of surgery for aortic aneurysm.
  
  
  CONCLUSIONS
  Careful clinical, biochemical, imaging and nor-iodo-cholesterol scintigraphy with definite uptake by the adrenal mass, a strong indicator of benignancy, allows surgical indication to be postponed, and is likely to cancel it if, at one-year follow-up, imaging studies show no change in the mass.
authors.affiliation: Clinique chirurgicale adultes est, service de chirurgie générale et endocrinienne, hôpital Claude-Huriez, CHU Lille, 1, rue Michel-Polonowski, 59037 Lille, France.
authors.forename: E
authors.initials: E
authors.lastname: Mirallié
authors.forename: M
authors.initials: M
authors.lastname: Jafari
authors.forename: F
authors.initials: F
authors.lastname: Pattou
authors.forename: O
authors.initials: O
authors.lastname: Ernst
authors.forename: D
authors.initials: D
authors.lastname: Huglo
authors.forename: B
authors.initials: B
authors.lastname: Carnaille
authors.forename: C
authors.initials: C
authors.lastname: Proye
mesh_terms: D000236:Adenoma / Q000473:pathology; D000307:Adrenal Gland Diseases / Q000473:pathology*; D000310:Adrenal Gland Neoplasms / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed